Date
Event
27
Jan
Hatch-Waxman 101 for the Emerging Life Science Company
Wednesday, Jan 27, 20211:00—2:00pm
This Cooley program is targeted at innovative life science companies that have filed, or will soon file, NDA or 505(b)(2) applications and are anticipating their first Hatch-Waxman litigation. We will discuss pre-litigation considerations, including Orange Book patent listing, the interplay between patent and regulatory exclusivities and pre-suit due diligence activities. We will also discuss Hatch-Waxman litigation mechanics, including Notice Letters, 30-month stays of FDA ANDA approval and lawsuit timing.
Find out more about the speakers and register.